Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Platelet function under high-shear conditions from platelet concentrates.

Jilma-Stohlawetz P, Horvath M, Eichelberger B, Koren D, Jilma B, Panzer S.

Transfusion. 2008 Jan;48(1):129-35. Epub 2007 Sep 24.

PMID:
17894788
2.

Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.

Picker SM, Schneider V, Gathof BS.

Transfusion. 2009 Jun;49(6):1224-32. doi: 10.1111/j.1537-2995.2009.02092.x. Epub 2009 Feb 10.

PMID:
19220821
3.

The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.

Tynngård N, Lindahl TL, Trinks M, Studer M, Berlin G.

Transfusion. 2008 Apr;48(4):715-22. doi: 10.1111/j.1537-2995.2007.01610.x. Epub 2008 Jan 15.

PMID:
18208416
4.

Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R.

Horvath M, Eichelberger B, Koren D, Böhm A, Ay C, Jilma B, Panzer S, Jilma-Stohlawetz P.

Transfusion. 2010 May;50(5):1036-42. doi: 10.1111/j.1537-2995.2009.02543.x. Epub 2009 Dec 29.

PMID:
20051058
5.

The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.

Zeiler T, Gritzka D, Karger R, Kretschmer V.

Transfusion. 2004 Sep;44(9):1300-5.

PMID:
15318852
6.

Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.

Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G.

Transfusion. 2005 Jun;45(6):911-9.

PMID:
15934989
7.

Use of the DiaMed Impact R to test platelet function in stored platelet concentrates.

Morrison A, Hornsey VS, Prowse CV, Macgregor IR.

Vox Sang. 2007 Aug;93(2):166-72.

PMID:
17683361
8.
9.

Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.

Skripchenko A, Kurtz J, Moroff G, Wagner SJ.

Transfusion. 2008 Jul;48(7):1469-77. doi: 10.1111/j.1537-2995.2008.01733.x. Epub 2008 May 13.

PMID:
18482181
10.
12.

Platelet ADP response deteriorates in synthetic storage media.

Keuren JF, Cauwenberghs S, Heeremans J, de Kort W, Heemskerk JW, Curvers J.

Transfusion. 2006 Feb;46(2):204-12.

PMID:
16441596
13.

Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.

Perseghin P, Mascaretti L, Speranza T, Belotti D, Baldini V, Dassi M, Riva M, Pogliani EM, Sciorelli G.

Transfusion. 2004 Jan;44(1):125-30.

PMID:
14692978
14.

Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide.

Hornsey VS, McMillan L, Morrison A, Drummond O, Macgregor IR, Prowse CV.

Transfusion. 2008 Dec;48(12):2508-14. doi: 10.1111/j.1537-2995.2008.01884.x. Epub 2008 Aug 1.

PMID:
18680547
15.

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

Li J, Lockerbie O, de Korte D, Rice J, McLean R, Goodrich RP.

Transfusion. 2005 Jun;45(6):920-6.

PMID:
15934990
16.

Evaluation of the Impact-R for monitoring the platelet storage lesion.

Albanyan AM, Murphy MF, Harrison P.

Platelets. 2009 Feb;20(1):1-6. doi: 10.1080/09537100802468653.

PMID:
19172514
17.
18.

Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.

Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J.

Transfusion. 2008 Oct;48(10):2114-21. doi: 10.1111/j.1537-2995.2008.01849.x. Epub 2008 Jul 17.

PMID:
18647365
19.
20.

Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.

Albanyan AM, Harrison P, Murphy MF.

Transfusion. 2009 Jan;49(1):108-17. doi: 10.1111/j.1537-2995.2008.01942.x. Epub 2008 Oct 14.

PMID:
18954396

Supplemental Content

Support Center